Founded in Seoul in 2001, Jeisys is a global developer, manufacturer, and supplier of medical aesthetic devices, specifically energy-based devices (EBDs), addressing skin diseases. It specializes in leading radio frequency (RF) and high-intensity focused ultrasound (HIFU) non-invasive technologies for treating skin conditions such as melasma, rosacea, telangiectasia, hyperpigmentation, acne scarring, and vascular lesions. These treatment methods also minimize the use of needles, limiting patient discomfort and downtime.

Key Value Creation Levers :
• Market entry into Europe and Australia.
• Go-direct commercial strategy in the US and Brazil.
• NAMSA regulatory synergies across the US, Asia, and Europe.
• Commercial synergies with ARCHIMED Consumer Health companies.